Condition (MeSH)
Yaws
ClinicalTrials.gov lists 16 trials for Yaws or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Yaws itself; the rest are tagged with a narrower condition beneath it.
When did Yaws trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2023 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 4 |
| 2016 | 1 |
| 2015 | 1 |
| 2013 | 2 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 16 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Yaws trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 5 |
| Phase 4 | 2 |
| Not applicable | 4 |
| Observational | 3 |
How many Yaws trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Completed | 13 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Yaws? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Ivermectin | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Azithromycin | 5 |
| Azithromycin on Day 1 | 1 |
| Albendazole on Day 1 | 1 |
| Topical antiseptic treatment | 1 |
| Ivermectin on Day 1 | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Yaws? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication. | The New England journal of medicine | 2022 | Yes |
| LAMP4yaws: <i>Treponema pallidum</i>, <i>Haemophilus ducreyi</i> loop mediated isothermal amplification - protocol for a cross-sectional, observational, diagnostic accuracy study. | BMJ open | 2022 | Yes |
| Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. | Lancet (London, England) | 2018 | Yes |
| Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea. | The Lancet. Global health | 2018 | Yes |
| Effectiveness of single-dose azithromycin to treat latent yaws: a longitudinal comparative cohort study. | The Lancet. Global health | 2017 | Yes |
Showing 5 of 9 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.